Healthcare Pharmaceuticals Limited (HPL) is committed to enhancing global health by delivering high-quality pharmaceutical products and innovative solutions. Established in Bangladesh, HPL operates under stringent quality standards, supported by partnerships with renowned pharmaceutical experts like Roche. The company’s diverse product portfolio includes over 630 registered medicines, spanning various therapeutic categories such as analgesics, antibiotics, anticancer drugs, and antidiabetic medications. Their offerings encompass multiple dosage forms including tablets, injections, and topical products, ensuring accessibility to essential healthcare solutions.

With a focus on quality, innovation, and safety, HPL adheres to Good Manufacturing Practices (GMP) and prioritizes the efficacy of its formulations. The company serves a broad international market, exporting to over 32 countries across Asia, Africa, and beyond, while continuously expanding its production capabilities. HPL fosters a culture of collaboration among its 7,800 employees, driving the mission of improving lives through effective and safe medicines. Their commitment to ethical practices and sustainable growth solidifies HPL's reputation as a leader in the pharmaceuticals industry.